Media

GPhA: Proposed Budget Highlights Need for Historic User Fee Proposals 2.14.2012

GPhA: Projected Savings from Patent Settlement Ban Rely on Faulty Assumptions 11.09.2011

GPhA Calls on “Super Committee” to Pursue Policies Encouraging the Use of Generic Medications 9.22.2011

FTC Continues to Mislead Consumers on Pro-Consumer Patent Settlements 8.31.2011

GPhA: Next Generation of Generics Owe Savings to Pro-Consumer Patent Settlements 7.29.2011

GPhA: FTC’s Flawed Understanding of Patent Settlements Misleads Consumers 5.03.2011

GPhA Statement on Administration’s FY 2012 Budget Request; GPhA Rejects Proposal to Ban Settlements Based on Grossly Flawed Economic Analysis 2.14.2011

New Government Brief Shows Dramatic Growth in Generic Drug Use Has Generated ‘Substantial Savings’ for Consumers 12.17.2010

GPhA Says Recent Cipro Decision Again Demonstrates Patent Settlements Are Pro-Competitive and Benefit Consumers 9.09.2010

GPhA Says New Economic Analysis Shows FTC and CBO Erred in Projecting Savings from Patent Settlement Ban 8.12.2010

GPhA Comments on 15-15 Senate Appropriations Committee Vote on Patent Settlements 7.30.2010

GPhA: FTC Position Misguided on Consumer Benefits of Patent Litigation Settlements 7.27.2010

GPhA Warns that House-Passed Curb on Settlements Will Delay Access to Affordable Medicines 7.02.2010

Statement from GPhA on Upcoming House Vote on Patent Settlements in the War Funding Bill 6.30.2010

Statement from GPhA on FTC Commissioner Jon Leibowitz’s Congressional Testimony on Patent Settlements 6.09.2010